{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:37:56Z","timestamp":1792715876628,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"The Susan G Komen Breast Cancer Foundation Inc","doi-asserted-by":"publisher","award":["CTA241187107"],"award-info":[{"award-number":["CTA241187107"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["NUL"],"award-info":[{"award-number":["NUL"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013700","name":"National Comprehensive Cancer Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001286","name":"Pan-Massachusetts Challenge","doi-asserted-by":"publisher","award":["DFCI BOC"],"award-info":[{"award-number":["DFCI BOC"]}],"id":[{"id":"10.13039\/100001286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011145","name":"Fashion Footwear Association of New York","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.esmoop.2026.108540","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:04:52Z","timestamp":1789419892000},"page":"108540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor genomic landscape of older patients with metastatic breast cancer\u2606"],"prefix":"10.1016","volume":"11","author":[{"given":"H.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0084-4775","authenticated-orcid":false,"given":"K.D.","family":"Brantley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8567-9627","authenticated-orcid":false,"given":"T.","family":"Grinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kodali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0386-5223","authenticated-orcid":false,"given":"G.J.","family":"Kirkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1174-1541","authenticated-orcid":false,"given":"A.B.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Avdulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Files","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Suggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5940-8671","authenticated-orcid":false,"given":"S.M.","family":"Tolaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5989-6636","authenticated-orcid":false,"given":"A.C.","family":"Garrido-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Cherniack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.U.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.esmoop.2026.108540_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108540_bib2","first-page":"524","article-title":"Breast cancer statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108540_bib3","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/ijc.31950","article-title":"Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort","volume":"144","author":"Johansson","year":"2019","journal-title":"Int J Cancer"},{"issue":"27","key":"10.1016\/j.esmoop.2026.108540_bib4","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1200\/JCO.2015.65.8013","article-title":"Subtype-dependent relationship between young age at diagnosis and breast cancer survival","volume":"34","author":"Partridge","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108540_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41467-021-27889-y","article-title":"Age influences on the molecular presentation of tumours","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108540_bib6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1056\/NEJMp2106089","article-title":"Treatment of older adults with cancer\u2014addressing gaps in evidence","volume":"385","author":"Bertagnolli","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108540_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41576-021-00338-8","article-title":"Clinical cancer genomic profiling","volume":"22","author":"Chakravarty","year":"2021","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108540_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12885-020-6684-z","article-title":"Mutational landscape differences between young-onset and older-onset breast cancer patients","volume":"20","author":"Mealey","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.esmoop.2026.108540_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12916-015-0504-3","article-title":"Genomic aberrations in young and elderly breast cancer patients","volume":"13","author":"Azim","year":"2015","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108540_bib10","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/s41588-019-0507-7","article-title":"The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies","volume":"51","author":"Angus","year":"2019","journal-title":"Nat Genet"},{"issue":"15","key":"10.1016\/j.esmoop.2026.108540_bib11","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1158\/1078-0432.CCR-16-3115","article-title":"Genetic heterogeneity in therapy-na\u00efve synchronous primary breast cancers and their metastases","volume":"23","author":"Ng","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108540_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ccell.2017.07.005","article-title":"Genomic evolution of breast cancer metastasis and relapse","volume":"32","author":"Yates","year":"2017","journal-title":"Cancer Cell"},{"issue":"7757","key":"10.1016\/j.esmoop.2026.108540_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-019-1056-z","article-title":"Genomic characterization of metastatic breast cancers","volume":"569","author":"Bertucci","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108540_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41523-025-00781-4","article-title":"Genomic landscape of breast cancer in elderly patients","volume":"11","author":"Selenica","year":"2025","journal-title":"NPJ Breast Cancer"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108540_bib15","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.esmoop.2026.108540_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2026.104816","article-title":"Characteristics, treatment and survival of older patients with metastatic triple negative breast cancer from the ESME mBC real-world national cohort: a comparison with younger women","volume":"88","author":"Mair\u00e9","year":"2026","journal-title":"Breast"},{"issue":"suppl 1","key":"10.1016\/j.esmoop.2026.108540_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/0284186X.2015.1115118","article-title":"Trends in breast cancer in the elderly in Denmark, 1980-2012","volume":"55","author":"Jensen","year":"2016","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108540_bib18","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1371\/journal.pmed.0030025","article-title":"Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden","volume":"3","author":"Eaker","year":"2006","journal-title":"PLoS Med"},{"issue":"suppl 1","key":"10.1016\/j.esmoop.2026.108540_bib19","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0960-9776(19)31125-7","article-title":"Impact of older age on local treatment decisions","volume":"48","author":"Ugurlu","year":"2019","journal-title":"Breast"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108540_bib20","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(20)30741-5","article-title":"Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)","volume":"22","author":"Biganzoli","year":"2021","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108540_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4048\/jbc.2024.0190","article-title":"Breast cancer in older patients aged 70 years and above: treatment adherence and oncologic outcomes","volume":"28","author":"Kim","year":"2025","journal-title":"J Breast Cancer"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108540_bib22","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP Guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.esmoop.2026.108540_bib23","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.22.02864","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO\u2013College of American Pathologists Guideline update","volume":"41","author":"Wolff","year":"2023","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108540_bib24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"7809","key":"10.1016\/j.esmoop.2026.108540_bib25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.esmoop.2026.108540_bib26","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.esmoop.2026.108540_bib27","doi-asserted-by":"crossref","first-page":"D1210","DOI":"10.1093\/nar\/gkad986","article-title":"COSMIC: a curated database of somatic variants and clinical data for cancer","volume":"52","author":"Sondka","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.esmoop.2026.108540_bib28","article-title":"OncoKB: a precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108540_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.annonc.2019.11.010","article-title":"Prevalence and mutational determinants of high tumor mutation burden in breast cancer","volume":"31","author":"Barroso-Sousa","year":"2020","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1016\/j.esmoop.2026.108540_bib30","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.3390\/cancers15153997","article-title":"Tumor mutational burden in breast cancer: current evidence, challenges, and opportunities","volume":"15","author":"Barroso-Sousa","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108540_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the Cancer Genome Atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108540_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","article-title":"The genomic landscape of endocrine-resistant advanced breast cancers","volume":"34","author":"Razavi","year":"2018","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.esmoop.2026.108540_bib33","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1158\/1078-0432.CCR-09-0632","article-title":"PIK3CA mutation associates with improved outcome in breast cancer","volume":"15","author":"Kalinsky","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108540_bib34","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/jamaoncol.2016.0339","article-title":"Effects of estrogen receptor and human epidermal growth factor receptor-2 levels on the efficacy of trastuzumab: a secondary analysis of the HERA Trial","volume":"2","author":"Loi","year":"2016","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108540_bib35","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1158\/2159-8290.CD-20-1557","article-title":"Impact of HER2 heterogeneity on treatment response of early-stage HER2-positive breast cancer: phase II neoadjuvant clinical trial of T-DM1 combined with pertuzumab","volume":"11","author":"Filho","year":"2021","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108540_bib36","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1309\/AJCPIRL4GUVGK3YX","article-title":"HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer","volume":"142","author":"Lee","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108540_bib37","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3346\/jkms.2009.24.5.910","article-title":"Weekly paclitaxel and trastuzumab as a first-line therapy in patients with HER2-overexpressing metastatic breast cancer: magnitude of HER2\/neu amplification as a predictive factor for efficacy","volume":"24","author":"Han","year":"2009","journal-title":"J Korean Med Sci"},{"issue":"19","key":"10.1016\/j.esmoop.2026.108540_bib38","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","article-title":"Trastuzumab emtansine for HER2-positive advanced breast cancer","volume":"367","author":"Verma","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108540_bib39","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jgo.2019.06.004","article-title":"HER2-targeted treatment for older patients with breast cancer: an expert position paper from the International Society of Geriatric Oncology","volume":"10","author":"Brain","year":"2019","journal-title":"J Geriatr Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108540_bib40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(19)30863-0","article-title":"Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study","volume":"21","author":"Swain","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108540_bib41","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41591-024-03462-0","article-title":"Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial","volume":"31","author":"Okines","year":"2025","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108540_bib42","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.annonc.2023.08.003","article-title":"Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial","volume":"34","author":"Jhaveri","year":"2023","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108540_bib43","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.annonc.2020.11.011","article-title":"Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2\u2013negative advanced breast cancer: final overall survival results from SOLAR-1","volume":"32","author":"Andr\u00e9","year":"2021","journal-title":"Ann Oncol"},{"issue":"22","key":"10.1016\/j.esmoop.2026.108540_bib44","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","article-title":"Capivasertib in hormone receptor\u2013positive advanced breast cancer","volume":"388","author":"Turner","year":"2023","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108540_bib45","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.annonc.2020.05.001","article-title":"Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer","volume":"31","author":"Rugo","year":"2020","journal-title":"Ann Oncol"},{"issue":"16_suppl","key":"10.1016\/j.esmoop.2026.108540_bib46","doi-asserted-by":"crossref","first-page":"e13059","DOI":"10.1200\/JCO.2023.41.16_suppl.e13059","article-title":"The association between baseline patient characteristics and alpelisib-induced hyperglycaemia in patients with HR+, HER2-, PIK3CA-mutated metastatic breast cancer","volume":"41","author":"Godina","year":"2023","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.esmoop.2026.108540_bib47","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1056\/NEJMra1704560","article-title":"Phosphatidylinositol 3-kinase, growth disorders, and cancer","volume":"379","author":"Goncalves","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.esmoop.2026.108540_bib48","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1158\/2159-8290.CD-23-0945","article-title":"A new wave of PI3K\u03b1 inhibitors","volume":"13","author":"Kearney","year":"2023","journal-title":"Cancer Discov"},{"issue":"15_suppl","key":"10.1016\/j.esmoop.2026.108540_bib49","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1200\/JCO.2021.39.15_suppl.1091","article-title":"Genomic evaluation of tumor mutational burden-high (TMB-H) versus TMB-low (TMB-L) metastatic breast cancer to reveal unique mutational features","volume":"39","author":"Sammons","year":"2021","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108540_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101253","article-title":"29P Prevalence of high tumor mutational burden (TMB) in patients with metastatic breast cancer (mBC) assessed by liquid biopsy (LB)","volume":"8","author":"Ribeiro","year":"2023","journal-title":"ESMO Open"},{"issue":"suppl 5","key":"10.1016\/j.esmoop.2026.108540_bib51","article-title":"Abstract P2-23-09: ultra-high tumor mutation burden in metastatic\/clinically advanced breast cancer (MBC)","volume":"83","author":"Fanucci","year":"2023","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108540_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13073-016-0333-9","article-title":"The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine","volume":"8","author":"Garofalo","year":"2016","journal-title":"Genome Med"},{"issue":"suppl 16","key":"10.1016\/j.esmoop.2026.108540_bib53","doi-asserted-by":"crossref","first-page":"e15173","DOI":"10.1200\/JCO.2023.41.16_suppl.e15173","article-title":"Whole genome sequencing for more accurate TMB and mutational signatures in common cancers","volume":"41","author":"Lee","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108540_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"issue":"5","key":"10.1016\/j.esmoop.2026.108540_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100577","article-title":"The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression","volume":"7","author":"Kim","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.esmoop.2026.108540_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.538174","article-title":"Efficacy of anti-PD-1\/PD-L1 monotherapy or combinational therapy in patients aged 75 years or older: a study-level meta-analysis","volume":"11","author":"Nie","year":"2021","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.esmoop.2026.108540_bib57","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1001\/jamaoncol.2021.4960","article-title":"Clinical outcomes and toxic effects of single-agent immune checkpoint inhibitors among patients aged 80 years or older with cancer: a multicenter international cohort study","volume":"7","author":"Nebhan","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.esmoop.2026.108540_bib58","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/EDBK_201435","article-title":"Immunotherapy in older adults with advanced cancers: implications for clinical decision-making and future research","volume":"38","author":"Kanesvaran","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926024853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926024853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:42:41Z","timestamp":1792712561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926024853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2059702926024853"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108540","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor genomic landscape of older patients with metastatic breast cancer\u2606","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108540"}}